Protocol for Escitalopram and Language Intervention for Subacute Aphasia (ELISA): A randomized, double blind, placebo-controlled trial

In this forthcoming multicenter, prospective, randomized, double-blind placebo-controlled trial, we will investigate the augmentative effects of a selective serotonin reuptake inhibitor, escitalopram, on language therapy in individuals with post-stroke aphasia. We hypothesize that, when combined wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockbridge, Melissa D., Fridriksson, Julius, Sen, Souvik, Bonilha, Leonardo, Hillis, Argye E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699636/
https://www.ncbi.nlm.nih.gov/pubmed/34941929
http://dx.doi.org/10.1371/journal.pone.0261474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699636/
https://www.ncbi.nlm.nih.gov/pubmed/34941929
http://dx.doi.org/10.1371/journal.pone.0261474

Ejemplares similares